Xiaoguang Lei, PhD
Founder
• Professor, College of Chemistry and Molecular Engineering, Peking University • Pioneering research in chemical biology, translational medicine, and innovative drug discovery
Yong Yang, MD
Co-Founder
• Vice President of Hospital for Skin Diseases, Chinese Academy of MedicalSciences • First to demonstrate Naᵥ 1.7's pathophysiological role in erythromelalgia
Shun Su, PhD
CSO
• Former Principal Scientist at Bristol Myers Squibb • Proven expertise in small-molecule drug discovery
Daohong Liao, PhD
COO
• Former senior researcher at Pharmaron and Department of New Drug R&D, PKUSIM • Broad experiences spanning Med Chem to CMC
Bingjie Wang, PhD
CBO
• Former biotech investor • Experienced in high-profile projects and portfolio management